| 7 | | || ID || Subject of Evaluation || Public comment received || Public consultation outcome || Evaluation outcome || |
| 8 | | || EVA00122 || 1H-Benzotriazole and its mono-substituted derivatives || Yes - Information on exposure and hazard; Other (use of read across) || A variation to the evaluation statement was required. Evaluation statement has been amended to include Australian use information. Minor amendments were made to the Evaluation statement to clarify the read-across approach for the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) classification. As the hazard information had already been considered, no change has been made to the GHS classification.|| Recommendation to regulatory body (workers). Information relating to safe introduction and use. || |
| 9 | | || EVA00147 || Phenolic benzotriazoles||Yes - Information on exposure and hazard || A variation to the evaluation statement was required. Evaluation statement has been amended to include Australian use information. As the hazard information had already been considered, no change has been made to the GHS classification.|| Recommendation to regulatory body (workers). Information relating to safe introduction and use. || |
| 10 | | || EVA00151 || Tellurium and its inorganic compounds || No || || Recommendation to regulatory body (workers). || |
| 11 | | || EVA00153 || Extracts and essential oils primarily composed of methyl salicylate || No || || Recommendation to regulatory body (public health). Recommendation to regulatory body (workers). Information relating to safe introduction and use. || |
| 12 | | || EVA00162 || Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester (Homosalate) || Yes - Exposure information || A variation to the evaluation statement was required. The exposure calculations were amended to reflect information provided. This did not result in a change to the recommendation. || Recommendation to regulatory body (public health). Information relating to safe introduction and use. || |
| | 5 | || ID || Subject of Evaluation || Public comment received || Public consultation outcome || Evaluation outcome || |
| | 6 | || EVA00122 || 1H-Benzotriazole and its mono-substituted derivatives || Yes - Information on exposure and hazard; Other (use of read across) || A variation to the evaluation statement was required. Evaluation statement has been amended to include Australian use information. Minor amendments were made to the Evaluation statement to clarify the read-across approach for the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) classification. As the hazard information had already been considered, no change has been made to the GHS classification.|| Recommendation to regulatory body (workers). Information relating to safe introduction and use. || |
| | 7 | |||||||| https://www.industrialchemicals.gov.au/sites/default/files/2024-12/EVA00122%20-%20Evaluation%20Statement%20-%2016%20December%202024.pdf |||||||| |
| | 8 | || EVA00147 || Phenolic benzotriazoles||Yes - Information on exposure and hazard || A variation to the evaluation statement was required. Evaluation statement has been amended to include Australian use information. As the hazard information had already been considered, no change has been made to the GHS classification.|| Recommendation to regulatory body (workers). Information relating to safe introduction and use. || |
| | 9 | |||||||| https://www.industrialchemicals.gov.au/sites/default/files/2024-12/EVA00147%20-%20Evaluation%20Statement%20-%2016%20December%202024.pdf |||||||| |
| | 10 | || EVA00151 || Tellurium and its inorganic compounds || No || || Recommendation to regulatory body (workers). || |
| | 11 | |||||||| https://www.industrialchemicals.gov.au/sites/default/files/2024-12/EVA00151%20-%20Evaluation%20Statement%20-%2016%20December%202024.pdf |||||||| |
| | 12 | || EVA00153 || Extracts and essential oils primarily composed of methyl salicylate || No || || Recommendation to regulatory body (public health). Recommendation to regulatory body (workers). Information relating to safe introduction and use. || |
| | 13 | |||||||| https://www.industrialchemicals.gov.au/sites/default/files/2024-12/EVA00153%20-%20Evaluation%20Statement%20-%2016%20December%202024.pdf |||||||| |
| | 14 | || EVA00162 || Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester (Homosalate) || Yes - Exposure information || A variation to the evaluation statement was required. The exposure calculations were amended to reflect information provided. This did not result in a change to the recommendation. || Recommendation to regulatory body (public health). Information relating to safe introduction and use. || |
| | 15 | |||||||| https://www.industrialchemicals.gov.au/sites/default/files/2024-12/EVA00162%20-%20Evaluation%20Statement%20-%2016%20December%202024.pdf |||||||| |
| 14 | | || EVA00164 || Chemicals that are unlikely to require further regulation to manage risks to environment || Yes - Information on exposure and hazard || A variation to the evaluation statement was not required. The exposure information provided did not indicate a higher risk exposure scenario compared with the assessed exposure scenario. As the hazard information had already been considered, no change has been made to the risk conclusions. || No new means of managing risk are proposed. || |
| 15 | | || EVA00178 || Phenol, 4,4'-(1-methylethylidene)bis- (Bisphenol A) || Yes - Information on exposure and hazard || A variation to the evaluation statement was required. Evaluation statement has been amended to include Australian use information. As the hazard information had already been considered, no change has been made to the GHS classification. || Recommendation to regulatory body (workers). Information relating to safe introduction and use. || |
| | 17 | |||||||| https://www.industrialchemicals.gov.au/sites/default/files/2024-12/EVA00163%20-%20Evaluation%20Statement%20-%2016%20December%202024.pdf |||||||| |
| | 18 | || EVA00164 || Chemicals that are unlikely to require further regulation to manage risks to environment || Yes - Information on exposure and hazard || A variation to the evaluation statement was not required. The exposure information provided did not indicate a higher risk exposure scenario compared with the assessed exposure scenario. As the hazard information had already been considered, no change has been made to the risk conclusions. || No new means of managing risk are proposed. || |
| | 19 | |||||||| https://www.industrialchemicals.gov.au/sites/default/files/2024-12/EVA00164%20-%20Evaluation%20Statement%20-%2016%20December%202024.pdf |||||||| |
| | 20 | || EVA00178 || Phenol, 4,4'-(1-methylethylidene)bis- (Bisphenol A) || Yes - Information on exposure and hazard || A variation to the evaluation statement was required. Evaluation statement has been amended to include Australian use information. As the hazard information had already been considered, no change has been made to the GHS classification. || Recommendation to regulatory body (workers). Information relating to safe introduction and use. || |
| | 21 | |||||||| https://www.industrialchemicals.gov.au/sites/default/files/2024-12/EVA00178%20-%20Evaluation%20Statement%20-%2016%20December%202024.pdf |||||||| |
